Novel Bioactive Compound Production by Microbial Biota: Potential Antimicrobials: Potential antimicrobials produced by microbial biota

Sara  Hayee

doi:10.52229/pbmj.v3i1.8

Authors

Sara Hayee Government Post Graduate College for Women, Samanabad, Lahore, Pakistan

DOI:

https://doi.org/10.52229/pbmj.v3i1.8

Abstract

Man is always trying to make his life easier and accomplished. He has faced mass destruction in history due to epidemics like small pox, malaria and plague. In order to combat diseases, exploration of man led him to search for causative agents and their control. A time reached when it was found that microbes are themselves a source of potent metabolites which have proved to be effective as drugs and medicines showing great antibiotic activity. It is necessary to find out new sources for potential new antimicrobial compounds. Several hundred important compounds have been isolated which have antibiotic activities and diverse chemical nature. But these compounds should have minimum toxicity to be useful clinically. Because of the increasing resistance of pathogens, there was a never ending desire and need to search for more. Bioactive Compounds have been extracted from microbes which are produced as secondary metabolites. Day by day, new compounds are being discovered giving a hope of golden future of drug industry. The current article emphasizes the importance and need to search for new bioactive compounds
to overcome infections caused by multiple drug resistant (MDR) and biofilm forming pathogens irrespective of the previously present knowledge.

References

Guaadaoui, A., Benaicha, S., Elmajdoub, N., Bellaoui, M. and Hamal, A. (2014). What is Bioactive compound? A combined definition for a preliminary consensus. Int. J. food Sci. Nutr.,3(3):174-179.

Mondol, M.A.M., Shin, H.J. and Islam, M.T. (2013). Diversity of Secondary Metabolites from Marine Bacillus Species: Chemistry and Biological Activity. Mar. Drugs.,11: 2846- 2872.

Kumar, P.A., Duraipandiyan, V. and Ignacimuthu. (2014). Isolation, screening and partial purification of antimicrobial antibiotics from soil Streptomyces sp. SCA 7. Kaosh. J. Med. Sci., 30: 435-446.

Elbendary, A.A., Hessain, A.H., El-Hariri, M.D., Seida, A.A., Moussa, I.M., Mubarak, A.S., Kabli, A.S., Hemeg, H.A. and El Jakee, J.K. (2018). Isolation of antimicrobial producing Actinobacteria from soil sample. Saud. J. Biol. Sci., 25: 44-46.

Gupta, C., Prakash, D. and Gupta, S., (2014). Natural useful therapeutic products from microbes. J. Microbiol. Exp., 1(1): 30-37.

Soria-Mercado, I.E., Villarreal-Gómez, L.J., Rivas, G.G. and Sánchez, N.E.A. (2012). Bioactive compounds from bacteria associated to marine algae. Biotechnology-Molecular Studies and Novel Applications for Improved Quality of Human Life. Croatia, pp.25-44.

Al-Zereini, W.A. (2014). Bioactive Crude Extracts from Four Bacterial Isolates of Marine Sediments from Red Sea, Gulf of Aqaba, Jordan. Jordn. J. Biol. Sci., 7(2):133-137.

Sun, W., Wu, W., Liu, X., Zaleta-Pinet, D.A. and Clark, B.R., (2019). Bioactive compounds isolated from marine-derived microbes in China: 2009–2018. Mar. Drugs, 17(6): 339.

Walia, A., Gupta, A.K. and Sharma, V. (2019). Role of bioactive compounds in human health. Act. Sci. Med. Sci., 3(9):25-33.

Singh, B.P., Rateb, M.E., Roudriguez-Couto, S., Polizeli, M.L.T.M. and Jun-Li, W. (2019). Editorial: Microbial secondary metabolites: recent developments and technological challenges. Front. Microbiol., 10:1-2.

Mushtaq, S., Abbasi, B.H., Uzair, B. and Abassi, R. (2018). Natural products as reservoirs of therapeutic agents. Excli. J., 17:420-451.

Hug, J.J., Bader, C.D., Remsker, M., Cirnski, K. and Muller, R. (2018).Concepts and methods to access novel antibiotics from actinomyces. Antibiotic.,7: 3-47.

Gaynes, R (2017). The discovery of Penicillin-new insights after more than 75 years of clinical use. Emerg. Infect. Dis., 23(5):849-853.

Tan, S.Y. and Tatsumara, Y. (2015). Alexander Fleming (1881–1955): Discoverer of penicillin.Singapore Med. J., 56 (7):366-367.

Lobanovska, M. and Pilla, G. (2017). Focus: Drug Development: Penicillin’s Discovery and Antibiotic Resistance: Lessons for the Future? Yale. J. Biol. Med., 90(1): 135.

Kesvan, S.S. and Hemlatha, R. (2015). Isolation and screening of antibiotic producing actinomycetes from garden soil of Sathyabama University, Chennai. Asian. J. Pharm. Clin. Res.,8 (6): 110-114.

Meij, V.D.A., Worsley S.F., Hutchings M.I. and Wezel G.P. (2017). Chemical ecology of antibiotic production by actinomycetes. Fems. Microbiol. Rev., 41: 392–416.

Woodruff, H.B. (2014). Selman A. Waksman, winner of the 1952 Nobel Prize for Physiology or Medicine. Appl. Environ. Microbiol., 80(1): 2-8.

Adam, D., Maciejewska, M., Naômé, A., Martinet, L., Coppieters, W., Karim, L., Baurain, D. and Rigali, S. (2018). Isolation, Characterization, and Antibacterial Activity of Hard-to-Culture Actinobacteria from Cave Moonmilk Deposits. Antibiotic.,2: 28.

Shaik, M., Girija-Sankar, G., Iswarya, M. and Rajitha, P. (2017). Isolation and characterization of bioactive metabolites producing marine Streptomyces parvulus strain sankarensis-A10. J. Gene. Engine.andbiotechnol., 15: 87-94.

Trabelsi, I., Oves, D., Morgan, B.G., Manteca, A., Geniloud, O. and Nour, M. (2016).Isolation, Characterization and antimicrobial activities of actinomycetes isolated from Tunisian Saline wetland. Microb. Biochem. Technol.,8(6):465-473.

Overy, D.P., Rämä, T., Oosterhuis, R., Walker, A.K. and Pang, K.L. (2019). The neglected marine fungi, sensustricto, and their isolation for natural products' discovery. Mar. Drugs, 17: E42.

Deshmukh, S.K., Prakash, V. and Ranjan, N., (2018). Marine fungi: A source of potential anticancer compounds. Front. Microbiol., 8: 2536.

Debbab, A., Aly, A.H., Lin, W.H. and Proksch, P. (2010).Bioactive Compounds from Marine Bacteria and Fungi. Microb. Biotechnol.,3(5): 544–563.

Mayer, A., Rodríguez, A.D., Taglialatela-Scafati, O. and Fusetani, N. (2017). Marine pharmacology in 2012–2013: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Mar. drugs, 15(9): 273.

Mullis, M.M., Rambo, I.M., Baker, B.J. and Reese, B.K. (2019).Diversity, ecology and prevalence antimicrobials in nature. Front. Microbiol.,10: 1-23.

Mazzoli, R. Riedel, K. and Pessione, E. (2017). Editorial: bioactive compounds from microbes. Front. Microbiol.,8: 392.

Devi, N.K.A., Rajendran, R. and Sundaram, S.K. 2011. Isolation and characterization of bioactive compounds from marine bacteria. Ind. J. of Natur. Prod. & Res.,2: 59-64.

Gurnani, N., Mehta, D., Gupta, M. and Mehta, B.K. (2014). Natural products: source of potential drugs. African J. Basic & Appl. Sci., 6(6): 171-186.

Sekurova, O.N., Schneider, O. and Zotchev, S.B., (2019). Novel bioactive natural products from bacteria via bioprospecting, genome mining and metabolic engineering. Microb. Biotechnol.,12(5): 828-844.

Shukla, R. (2015). Studies on bioactive compounds from different microorganisms. Int. J. Sci. & engineering Res., 6: 1225-1233.

Kulshreshtha, G. and Velusamy, P. (2012). Antibacterial potential of bioactive compounds from fermented culture of Pseudomonas aeruginosa SRM1 against Xanthomonasoryzaepv. OryzaeMinerva Biotecnologica., 24: 29-36.

Kostakioti, M., Hadjifrangiskou, M. and Hultgren, S. (2013). Bacterial Biofilms: Development, Dispersal, and Therapeutic Strategies in the Dawn of the Postantibiotic Era. Cold Spring Harb. Perspect. Med.,3: a010306.

Nong, X.H., Zhang, X.Y., Xu, X.Y., Wang, J. and Qi, S.H. (2016). Nahuoic Acids B–E, Polyhydroxy polyketides from the marine-derived Streptomyces sp. SCSGAA 0027. J. Nat. Prod., 79: 141–148.

Gunathilake, V.K. (2017). Marine bacteria and fungi as sources for bioactive compounds: present status and future trends. Int. J. Adv. Res., 5(9): 610-614.

Jain, P. and Gulati, J. (2012). Preliminary Screening for Antimicrobial Activity of Bacteria Isolated From Soil. J. Pharm. Res., 5(7):3540-3542.

Barbachyn, M.R. and Ford, C.W. (2003). Oxazolidinone structure–activity relationships leading to linezolid. Angew. Chem. Int. Ed., 42: 2010–2023.

Liaqat, I., Bachmann, R.T. and Edyvean, R.G. (2014). Type 2 quorum sensing monitoring, inhibition and biofilm formation in marine microrganisms. Curr. Microbial., 68(3): 342-351.

Flemming, H.C. and Wingender, J. (2010). The biofilm matrix. Nat. Rev. Microbiol.,8: 623–633.

Asokan, G.V., Ramadhan, T., Amad, E. and Sanad, H., (2019).WHO Global Priority Pathogens List: A Bibliometric Analysis of Medline-PubMed for Knowledge Mobilization to Infection Prevention and Control Practices in Bahrain. Oman. Med .J.,33(3):184-193.

Ventola, L.C. (2015). The antibiotic resistance crisis. P.& T., 40(4): 277-283.

Adnan, M., Alshammari, E., Patel, M., Ashraf, S.A., Khan, S. and Hadi, S. 2018. Significance and potential of marine microbial natural bioactive compounds against biofilms/biofouling: necessity for green chemistry. Peer J., 6: e5049.

Alasil, S.M.,Omar, R.,Ismail, S. and Yusof, M.Y. (2014).Antibiofilm Activity, Compound Characterization, and Acute Toxicity of Extract from a Novel Bacterial Species of Paenibacillus. Int. J. Microbiol., 2:1-11.

Wahl, M., Goecke, F., Labes, A., Dobretsov, S. and Weinberger, F. (2012). The second skin: ecological role of epibiotic biofilms on marine organisms. Front. Microbiol., 3: 292.

Engene, N., Choi, H., Esquenazi, E., Rottacker, E.C., Ellisman, M.H., Dorrestein, P.C. and Gerwick, W.H. (2011). Underestimated biodiversity as a major explanation for the perceived rich secondary metabolite capacity of the cyanobacterial genus Lyngbya. Environ. Microbial., 13(6): 1601-1610.